Summit Therapeutics (SMMT) Proxy filing summary

Executive summary

• Annual Meeting scheduled for June 10, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote by June 9, 2026.

Voting matters and shareholder proposals

• Election of nine directors is up for shareholder vote.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.

• Advisory vote on executive compensation (say-on-pay) is included.

• Proposal to amend the 2020 Stock Incentive Plan to increase the number of shares of common stock.

Board of directors and corporate governance

• Board recommends voting FOR all director nominees and all proposals.

• Proxy allows discretionary voting on other matters that may arise at the meeting.